Difference between revisions of "Team:GreatBay SCIE"

 
(44 intermediate revisions by 4 users not shown)
Line 8: Line 8:
 
<style>
 
<style>
 
#sideMenu, #top_title, .patrollink, #firstHeading, #home_logo, #sideMenu { display:none; }
 
#sideMenu, #top_title, .patrollink, #firstHeading, #home_logo, #sideMenu { display:none; }
#content { padding:0px; width:100%; margin-top:-7px; margin-left:0px; border:none;}
+
#content {padding:0px; width:100%; margin-top:-7px; margin-left:0px; border:none;}
 
body, html {background-color:white; width: 100%; height: 100%;}
 
body, html {background-color:white; width: 100%; height: 100%;}
 
#bodyContent h1, #bodyContent h2, #bodyContent h3, #bodyContent h4, #bodyContent h5 { margin-bottom: 0px; }
 
#bodyContent h1, #bodyContent h2, #bodyContent h3, #bodyContent h4, #bodyContent h5 { margin-bottom: 0px; }
Line 19: Line 19:
  
 
<a href="https://2021.igem.org/Team:GreatBay_SCIE" style="padding-right:0px">
 
<a href="https://2021.igem.org/Team:GreatBay_SCIE" style="padding-right:0px">
<img class="plogo" id="project_logo" src="https://static.igem.org/mediawiki/2021/6/6a/T--GreatBay_SCIE--Project_Logo.png" alt="logo" height="46"
+
<img class="plogo" id="project_logo" src="https://static.igem.org/mediawiki/2021/6/6a/T--GreatBay_SCIE--Project_Logo.png" alt="logo" height="46" style="position:absolute; margin-left:50px; margin-top:10px; left:0px;">
height:"46"; style="position:absolute; margin-left:30px; margin-top:10px;">
+
<img class="tlogo" id="team_logo" src="https://static.igem.org/mediawiki/2021/0/06/T--GreatBay_SCIE--Team_Logo.png" alt="logo" height="46" style="position:absolute; left:0; margin-top:13px!important; left:0px;">
<img class="tlogo" id="team_logo" src="https://static.igem.org/mediawiki/2021/0/06/T--GreatBay_SCIE--Team_Logo.png" alt="logo" height="46" style="position:absolute; left:0; margin-top:13px!important;">
+
 
</a>
 
</a>
 
+
<ul style="margin-left: -11px">   
<ul style="margin=left:-4px">   
+
 
         <li>
 
         <li>
 
             <a href="https://2021.igem.org/Team:GreatBay_SCIE">Home</a>
 
             <a href="https://2021.igem.org/Team:GreatBay_SCIE">Home</a>
Line 42: Line 40:
 
                
 
                
 
                 <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Design">Design</a></li>  
 
                 <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Design">Design</a></li>  
<li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Proof_Of_Concept">Proof of Concept</a></li>   
+
        <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Proof_Of_Concept">Proof of Concept</a></li>   
 
         <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Results">Results</a></li>     
 
         <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Results">Results</a></li>     
 
         <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Engineering">Engineering</a></li>
 
         <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Engineering">Engineering</a></li>
Line 54: Line 52:
 
             <ul>
 
             <ul>
 
                 <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Experiments">Experimental Design</a></li>
 
                 <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Experiments">Experimental Design</a></li>
<li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Safety">Safety</a></li>
+
                <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Results">Results</a></li> 
             
+
                <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Safety">Safety</a></li>
 
                 <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Notebook">Lab Notes</a></li>
 
                 <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Notebook">Lab Notes</a></li>
 
                 <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Protocol">Protocol</a></li>
 
                 <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Protocol">Protocol</a></li>
Line 68: Line 66:
 
                 <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Optimum_Aptamer_Concentration" >Optimum Liposome-Aptamer Ratio</a></li>
 
                 <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Optimum_Aptamer_Concentration" >Optimum Liposome-Aptamer Ratio</a></li>
 
                 <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Drug_Loading">Drug Loading</a></li>
 
                 <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Drug_Loading">Drug Loading</a></li>
                 <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/3D_Model">3D Models</a></li>
+
                 <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Dissociation_constant">Dissociation Constant</a></li>
 +
<li><a href="https://2021.igem.org/Team:GreatBay_SCIE/3D_Model">3D Models</a></li>
  
 
             </ul>
 
             </ul>
Line 75: Line 74:
 
             <a href="https://2021.igem.org/Team:GreatBay_SCIE/Human_Practices">Human Practices</a>
 
             <a href="https://2021.igem.org/Team:GreatBay_SCIE/Human_Practices">Human Practices</a>
 
             <ul>
 
             <ul>
 +
<li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Human_Practices">Integrated Human Practices</a></li>
 
                 <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Communication">Public Engagement & Education</a></li>
 
                 <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Communication">Public Engagement & Education</a></li>
                 <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Human_Practices">Integrated Human Practices</a></li>
+
                 <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/BreastCancerInChina">GreatBay_SCIE X Pink Ribbon</a></li>
 
                 <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Collaborations">Collaborations</a></li>
 
                 <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Collaborations">Collaborations</a></li>
 
                 <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Partnership">Partnership with SMS_Shenzhen</a></li>
 
                 <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Partnership">Partnership with SMS_Shenzhen</a></li>
 
             </ul>  
 
             </ul>  
 
         </li>
 
         </li>
        <!--<li>
 
            <a href="https://2021.igem.org/Team:GreatBay_SCIE/Notebook">Notebook</a>
 
            <ul>
 
                <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Methods">Methods</a></li>
 
  
        </li>-->
 
 
     </ul>
 
     </ul>
 
</div>
 
</div>
Line 92: Line 87:
  
 
<img id="head" src="https://static.igem.org/mediawiki/2021/7/7c/T--GreatBay_SCIE--Head.png" class="bg_image" style="z-index:9; width:100%;"></img>
 
<img id="head" src="https://static.igem.org/mediawiki/2021/7/7c/T--GreatBay_SCIE--Head.png" class="bg_image" style="z-index:9; width:100%;"></img>
<div class="title">Our Solution</div>
+
<center>
<p>KLJHgoiauhsfpiguhapsdhg;kajshdglkj</p>
+
<br>
<img id="header3" src="https://static.igem.org/mediawiki/2021/a/ac/T--GreatBay_SCIE--Head3.png" class="bg_image" style="z-index:8; width:100%;"></img>
+
<br>
 +
<br>
 +
<br>
 +
<br>
 +
<div class="title" style="align:center; font-family: Kumbh Sans;">| &nbsp;&nbsp; Our Solution &nbsp;&nbsp; |</div>
 +
</center>
  
<div class="title" style="font-family: Kumbh Sans; font-size:500% !important; text-align:center; font-weight: 700; color: gray; margin: 50px;">Check Out Our Promotion Video! ↓</div>
+
<br>
 +
<br>
 +
<center>
 +
<img id="header3" src="https://static.igem.org/mediawiki/2021/d/df/T--GreatBay_SCIE--OCK.png" class="bg_image" style="z-index:8; width:80%;"></img>
 +
</center>
 +
<br>
 +
<br>
 +
<br>
 +
<br>
 +
<br>
 +
<br>
 +
<br>
 +
<br>
 +
<!--
 +
<img id="header3" src="https://static.igem.org/mediawiki/2021/5/53/T--GreatBay_SCIE--Main_Transition_1.png" class="bg_image" style="z-index:8; width:100%;"></img>
 +
<img id="header3" src="https://static.igem.org/mediawiki/2021/a/ac/T--GreatBay_SCIE--Head3.png" class="bg_image" style="z-index:8; width:100%;"></img>
 +
-->
 +
<img id="header3" src="https://static.igem.org/mediawiki/2021/4/47/T--GreatBay_SCIE--Main_Transition_full.png" class="bg_image" style="z-index:8; width:100%;">
 +
<div class="title" style="font-family: Kumbh Sans; font-size:500% !important; text-align:center; font-weight: 700; color: #19232F; margin-top: 0px;margin: 50px;">Check Out Our Promotion Video! ↓</div>
  
 
<center>
 
<center>
Line 113: Line 131:
 
#cell li a h2:hover{background-color: #19232F; color: White; transition: all, 0.3s; }
 
#cell li a h2:hover{background-color: #19232F; color: White; transition: all, 0.3s; }
 
</style>
 
</style>
<ul class="row" id="cell">
+
<ul class="row" id="cell" style="margin-left: 0px;>
 +
 
 +
<li class="cell"> <!--别动这个东西 动了下面就乱了 不知道为什么 要有一个空li-->
 +
</li>
 
<li class="cell">
 
<li class="cell">
 
<img src="https://static.igem.org/mediawiki/2021/b/b0/T--GreatBay_SCIE--Team_Page_Logo.png" />
 
<img src="https://static.igem.org/mediawiki/2021/b/b0/T--GreatBay_SCIE--Team_Page_Logo.png" />
 
           <a href="https://2021.igem.org/Team:GreatBay_SCIE/Team"><h2>TEAM</h2></a>
 
           <a href="https://2021.igem.org/Team:GreatBay_SCIE/Team"><h2>TEAM</h2></a>
 
           <p>
 
           <p>
           Team GreatBay_SCIE consists of 15 enthusiastic and imaginative students, who aim to apply synthetic biology in real life.
+
           GreatBay_SCIE consists of 15 enthusiastic and imaginative students, who aim to apply synthetic biology in real life.
 
           </p>
 
           </p>
</li>
+
 
 
<li class="cell">
 
<li class="cell">
 
<img src="https://static.igem.org/mediawiki/2021/b/bf/T--GreatBay_SCIE--Project_Page_Logo.png" />
 
<img src="https://static.igem.org/mediawiki/2021/b/bf/T--GreatBay_SCIE--Project_Page_Logo.png" />
           <a href="https://2021.igem.org/Team:GreatBay_SCIE/Team"><h2>PROJECT</h2></a>
+
           <a href="https://2021.igem.org/Team:GreatBay_SCIE/Description"><h2>PROJECT</h2></a>
 
           <p>
 
           <p>
 
           We design an improved ligand-nanoparticle system which utilizes pH-sensitive aptamer to improve specificity on targeting HER2 proteins.
 
           We design an improved ligand-nanoparticle system which utilizes pH-sensitive aptamer to improve specificity on targeting HER2 proteins.
Line 130: Line 151:
 
<li class="cell">
 
<li class="cell">
 
<img src="https://static.igem.org/mediawiki/2021/4/40/T--GreatBay_SCIE--Lab_Logo.png"/>
 
<img src="https://static.igem.org/mediawiki/2021/4/40/T--GreatBay_SCIE--Lab_Logo.png"/>
           <a href="https://2021.igem.org/Team:GreatBay_SCIE/Team"><h2>LAB</h2></a>
+
           <a href="https://2021.igem.org/Team:GreatBay_SCIE/Experiments"><h2>LAB</h2></a>
 
           <p>
 
           <p>
           Our lab is made up by three main parts: aptamer experiment, nanoparticles manufacturing & modification and cell cultivation & experiments, of which results verified the availability and prospect of our system.
+
           Our lab is made up of three main parts: aptamer experiment, nanoparticles manufacturing & modification, and cell cultivation & experiments, of which results verified the availability and prospect of our system.
 
           </p>
 
           </p>
 
</li>
 
</li>
 
<li class="cell">
 
<li class="cell">
 
<img src="https://static.igem.org/mediawiki/2021/0/00/T--GreatBay_SCIE--Modeling_Logo.png" />
 
<img src="https://static.igem.org/mediawiki/2021/0/00/T--GreatBay_SCIE--Modeling_Logo.png" />
           <a href="https://2021.igem.org/Team:GreatBay_SCIE/Team"><h2>MODEL</h2></a>
+
           <a href="https://2021.igem.org/Team:GreatBay_SCIE/Model"><h2>MODEL</h2></a>
 
           <p>
 
           <p>
           We design two specific models which collect datas from both our experiments and published theses to calculate and predict the best conditions for our system.
+
           We design two specific models which collect datas from both of our experiments and publish theses to calculate and predict the best conditions for our system.
 
           </p>
 
           </p>
 
</li>
 
</li>
 
<li class="cell">
 
<li class="cell">
 
<img src="https://static.igem.org/mediawiki/2021/b/b1/T--GreatBay_SCIE--HP_Logo.png" />
 
<img src="https://static.igem.org/mediawiki/2021/b/b1/T--GreatBay_SCIE--HP_Logo.png" />
           <a href="https://2021.igem.org/Team:GreatBay_SCIE/Team"><h2>HP</h2></a>
+
           <a href="https://2021.igem.org/Team:GreatBay_SCIE/Human_Practices"><h2>HP</h2></a>
 
           <p>
 
           <p>
           Through contacting professors, doctors, and public service organizations, we not only receive useful advice for our methods and experiments but also learn the feelings and needs of breast cancer patients, which urges us to pay attention to those sufferers and the social problems behind.
+
           Through contacting professors, doctors, and public service organizations, we not only receive useful advice for our methods and experiments but also understand patients' feelings and know their needs.
 
           </p>
 
           </p>
 
</li>
 
</li>
 +
</ul>
 +
 +
<br>
 +
 +
<br>
 +
<br>
 +
<br>
 +
 +
<img id="head" src="https://static.igem.org/mediawiki/2021/d/da/T--GreatBay_SCIE--Bottom_Banner.png" class="bg_image" style="z-index:9; width:100%;"></img>
 
</body>
 
</body>
 
</html>
 
</html>

Latest revision as of 15:22, 21 October 2021






|    Our Solution    |










Check Out Our Promotion Video! ↓
  • TEAM

    GreatBay_SCIE consists of 15 enthusiastic and imaginative students, who aim to apply synthetic biology in real life.

  • PROJECT

    We design an improved ligand-nanoparticle system which utilizes pH-sensitive aptamer to improve specificity on targeting HER2 proteins.

  • LAB

    Our lab is made up of three main parts: aptamer experiment, nanoparticles manufacturing & modification, and cell cultivation & experiments, of which results verified the availability and prospect of our system.

  • MODEL

    We design two specific models which collect datas from both of our experiments and publish theses to calculate and predict the best conditions for our system.

  • HP

    Through contacting professors, doctors, and public service organizations, we not only receive useful advice for our methods and experiments but also understand patients' feelings and know their needs.